Bioceltix Future Growth
Future criteria checks 0/6
Bioceltix is forecast to grow earnings and revenue by 26.3% and 149% per annum respectively while EPS is expected to grow by 33.7% per annum.
Key information
26.3%
Earnings growth rate
33.7%
EPS growth rate
| Biotechs earnings growth | 36.4% |
| Revenue growth rate | 149.0% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 07 Aug 2024 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 13 | -9 | N/A | -2 | 1 |
| 12/31/2025 | N/A | -9 | N/A | 3 | 1 |
| 12/31/2024 | N/A | -16 | N/A | -14 | 1 |
| 6/30/2024 | N/A | -16 | -14 | -14 | N/A |
| 3/31/2024 | N/A | -15 | -14 | -13 | N/A |
| 12/31/2023 | N/A | -14 | -15 | -15 | N/A |
| 9/30/2023 | N/A | -13 | -13 | -12 | N/A |
| 6/30/2023 | N/A | -12 | -13 | -12 | N/A |
| 3/31/2023 | N/A | -10 | -11 | -10 | N/A |
| 12/31/2022 | N/A | -9 | -8 | -8 | N/A |
| 9/30/2022 | N/A | -8 | -6 | -6 | N/A |
| 3/31/2022 | N/A | -5 | -4 | -4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BCX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: BCX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: BCX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: BCX is forecast to have no revenue next year.
High Growth Revenue: BCX is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BCX's Return on Equity is forecast to be high in 3 years time